CRBU vs GOEV
Caribou Biosciences Inc (CRBU) versus GOEV (GOEV) — a side-by-side from cached financials, not a winner call.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
GOEV (GOEV) common stock.
Latest reported CRBU revenue for 2026-06-30 was $3.9M. Net income was -$49.4M. Revenue was up 62.5% from 2026-03-31 to 2026-06-30. CRBU currently screens at market cap $190.4M.
GOEV does not have a complete income-statement cache yet.
CRBU currently screens at market cap $190.4M.
Not investment advice. Open the CRBU and GOEV stock pages for the full models.
Not investment advice.